Palvella Therapeutics (PVLA) Shares Outstanding (Diluted) (2016 - 2026)
Palvella Therapeutics (PVLA) reported Shares Outstanding (Diluted) of 14.36 million for Q2 2026, up 29.9% from 11.05 million a year earlier and up 9.7% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends
For FY2025, Palvella Therapeutics posted Shares Outstanding (Diluted) of 11.25 million, up 405.5% from FY2024.
- Shares Outstanding (Diluted) has a five-year compound annual growth rate of -27.1% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 2.23 million in FY2024 (+24.1%), 1.79 million in FY2023 (-97.6%), 74.13 million in FY2022 (+14.8%) and 64.55 million in FY2021 (+18.5%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) since Q2 2023.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last eight quarters, with growth averaging 312.0% over the last eight quarters.
- The high point for year-over-year Shares Outstanding (Diluted) in five years was Q2 2025 (growth of 750.9%); the low point was Q2 2024 (a decline of 98.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 13.09 million (Q1 2026), 11.25 million (Q4 2025) and 11.06 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Palvella Therapeutics | 2.47 Bn | 2.23 Bn | - | 14.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.53 Mn |
| Jun 30, 2026 | 14.36 Mn |
| Mar 31, 2026 | 13.09 Mn |
| Dec 31, 2025 | 11.25 Mn |
| Sep 30, 2025 | 11.06 Mn |
| Jun 30, 2025 | 11.05 Mn |
| Mar 31, 2025 | 11.01 Mn |
| Dec 31, 2024 | 2.23 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.77 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.24 Mn |
| Jun 30, 2023 | 87.83 Mn |
| Mar 31, 2023 | 74.52 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 74.40 Mn |
| Jun 30, 2022 | 74.13 Mn |
| Mar 31, 2022 | 73.71 Mn |
| Dec 31, 2021 | 64.55 Mn |
API Access
Palvella Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();